Company news
Dimerix Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
SBN: New Investments
March 30, 2016
Exciting New Oil and Gas Opportunity
March 30, 2016
Update on EP 389 Farmin
March 30, 2016
SBN: Convertible Note Agreement
March 30, 2016
Non-Renounceable Rights Issue Announcement and Appendix 3B
March 30, 2016
Half Year Accounts
March 30, 2016
Consolidation Announcement and Notice of General Meeting
March 30, 2016
Reply to ASX Price Query
March 30, 2016
Preliminary Final Report & Full Year Statutory Accounts
March 30, 2016
Company Update
March 30, 2016
Manufacturing Service Agreement
March 30, 2016
Receipt of US Patent Allowance for Chronic Kidney Disease
February 18, 2016
Dimerix Receives Orphan Designation
February 11, 2016
Trademark Application & Extension
February 10, 2016
Sun Biomedical to Acquire Dimerix Bioscience
February 10, 2016
Sun Biomedical Completes First Phase of Oraline Testing
February 10, 2016
SBN Invests In Technology Accelerator Program
February 10, 2016
Private Clinic Initiated for DMX200 Trial
February 10, 2016
Non-Renounceable Rights Issue Offer Document
February 10, 2016
Manujfacturing Partnership - Test Strips
February 10, 2016
Manufacturing Partnership
February 10, 2016
Manufacturing Agreement
February 10, 2016
Madrid Convention Trademark Applications
February 10, 2016
First Patient in Phase II Trial
February 10, 2016
Exclusive Negotiation Arrangement
February 10, 2016
End of Negotiation Period with Parvulus Suisse SA
February 10, 2016
Dimerix Shareholders Sign Sale Agreements with SBN
February 10, 2016
Dimerix Receives Aust Patent Grant for Combination Therapy
February 10, 2016
Convertible Note Update
February 10, 2016
Board and Company Secretary Changes
February 10, 2016
Asthma Research Agreement & Capital Raising
February 10, 2016
Appendix 4E & Financial Statements
February 10, 2016
Appendix 4D- Half Year Report
February 10, 2016
Appendix 4D & Half-Year Financial Statements
February 10, 2016
Acitivity Report & Appendix 4C
February 10, 2016
Decks
The 5 newest of 83 decks. Every deck is listed under its year.
- Technical Presentation (October 2026)
Technical · 17 slides · Oct 23, 2026
- Canaccord Genuity Drug and Device Conference 2026
Conference · 35 slides · Oct 12, 2026
- ASX SMIDcaps Conference 2026
Conference · 16 slides · Sep 23, 2026
- E&P Healthcare Conference 2026
Conference · 22 slides · Sep 16, 2026
- Investor Presentation (September 2026)
Investor deck · 35 slides · Sep 7, 2026